<DOC>
	<DOCNO>NCT00318214</DOCNO>
	<brief_summary>This clinical research study experimental topical drug treatment chronic , neuropathic , diabetic foot ulcer . The purpose study determine safety experimental drug apply large , diabetic foot ulcer . The study also determine experimental drug safely promote heal diabetic foot ulcer well standard treatment currently available doctor . Patients participate study may receive active drug ( MRE0094 ) inactive drug ( placebo ) . What treatment patient receive determine chance ( like draw number hat ) . All patient receive additional care diabetic foot ulcer study . Participation study 4½ month .</brief_summary>
	<brief_title>Safety Efficacy Study MRE0094 Treat Large , Single Multiple , Chronic , Neuropathic , Diabetic Foot Ulcers</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<mesh_term>Diabetes Complications</mesh_term>
	<criteria>Participants include study must : Have type 1 type 2 diabetes mellitus . Have problem nerve foot . Have large ulcer multiple ulcer bottom surface foot present 3 week sufficient size qualify study . Be able apply study drug ulcer , caregiver . Be able visit doctor regularly 4½ month study . Participants may participate study : Their ulcer cause bad blood flow foot . Their ulcer infect . They wear offload device study take pressure ulcer . They certain disease , use certain type drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>toe ulcer</keyword>
	<keyword>heel ulcer</keyword>
	<keyword>foot ulcer</keyword>
	<keyword>diabetic foot</keyword>
	<keyword>diabetic foot</keyword>
	<keyword>complication diabetes</keyword>
</DOC>